Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayda Gursel

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Development of CpG ODN Based Vaccine Adjuvant FormulationsMayda Gursel, Ihsan Gursel
Biomaterials|November 30, 2010
Differential immune activation following encapsulation of immunostimulatory CpG oligodeoxynucleotide in nanoliposomesErdem Erikçi, Mayda Gursel, Ihsan Gürsel
European Journal of Immunology|September 11, 2002
CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cellsMayda Gursel, Daniela Verthelyi, Dennis M Klinman
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2004
Suppressive oligodeoxynucleotides inhibit Th1 differentiation by blocking IFN-gamma- and IL-12-mediated signalingHidekazu Shirota, Mayda Gursel, Dennis M Klinman
Mediators of Inflammation|December 5, 2013
Plasmacytoid dendritic cell response to CpG ODN correlates with CXCL16 expression and is inhibited by ox-LDLMayda Gursel, Dennis M Klinman, Ihsan Gursel
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2005
Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shockHidekazu Shirota, Ihsan Gursel, Mayda Gursel, et al.
Oncoimmunology|January 23, 2015
Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanoringsBilgi Gungor, Fuat Cem Yagci, Ihsan Gursel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
CXCL16 influences the nature and specificity of CpG-induced immune activationMayda Gursel, Ihsan Gursel, Howard S Mostowski, et al.
Plos One|January 12, 2016
Intestinal Microbiota in Patients with Spinal Cord InjuryBilgi Gungor, Emre Adiguzel, Ihsan Gursel, et al.
Current Opinion in Molecular Therapeutics|June 16, 2004
Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotidesKen J Ishii, Ihsan Gursel, Mayda Gursel, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Development of CpG ODN Based Vaccine Adjuvant FormulationsMayda Gursel, Ihsan Gursel
Biomaterials|November 30, 2010
Differential immune activation following encapsulation of immunostimulatory CpG oligodeoxynucleotide in nanoliposomesErdem Erikçi, Mayda Gursel, Ihsan Gürsel
European Journal of Immunology|September 11, 2002
CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cellsMayda Gursel, Daniela Verthelyi, Dennis M Klinman
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2004
Suppressive oligodeoxynucleotides inhibit Th1 differentiation by blocking IFN-gamma- and IL-12-mediated signalingHidekazu Shirota, Mayda Gursel, Dennis M Klinman
Mediators of Inflammation|December 5, 2013
Plasmacytoid dendritic cell response to CpG ODN correlates with CXCL16 expression and is inhibited by ox-LDLMayda Gursel, Dennis M Klinman, Ihsan Gursel
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2005
Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shockHidekazu Shirota, Ihsan Gursel, Mayda Gursel, et al.
Oncoimmunology|January 23, 2015
Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanoringsBilgi Gungor, Fuat Cem Yagci, Ihsan Gursel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
CXCL16 influences the nature and specificity of CpG-induced immune activationMayda Gursel, Ihsan Gursel, Howard S Mostowski, et al.
Plos One|January 12, 2016
Intestinal Microbiota in Patients with Spinal Cord InjuryBilgi Gungor, Emre Adiguzel, Ihsan Gursel, et al.
Current Opinion in Molecular Therapeutics|June 16, 2004
Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotidesKen J Ishii, Ihsan Gursel, Mayda Gursel, et al.
Pageof 5